Kalkine : Nasdaq Companies by Market Cap Spotlight on Immunome Inc

2 min read | June 03, 2025 07:31 AM PDT | By Team Kalkine Media

Google News:

Kalkine : Nasdaq Companies by Market Cap Spotlight on Immunome Inc — Image source: Shutterstock

Recent News

JPMorgan (NYSE:JPM) Leads Quiet Rotation In Financial Value Stocks

Exxon Mobil (NYSE:XOM) In Focus: What’s Catching Market Attention?

UnitedHealth (NYSE:UNH) Leads Healthcare Value Watch

Duke Energy (NYSE:DUK) Dividends Face A Key Market Test

Make Kalkine Media
My Trusted Source

ighlights

ProShare Advisors LLC added shares of Immunome, Inc. during the recent quarter.

Immunome, Inc. is listed on the Nasdaq index and operates within the biotechnology sector.

The acquisition reflects institutional interest in companies within the Nasdaq and related market segments.

Immunome, Inc. (NASDAQ:IMNM) operates in the biotechnology sector and is listed on the Nasdaq Companies by Market Cap. This company is part of a market segment that attracts attention for its innovative approaches in healthcare and research.

ProShare Advisors LLC’s Position in Immunome, Inc.

During the most recent quarter, ProShare Advisors LLC acquired shares of Immunome, Inc., a firm known for its work in biotechnology. This action was disclosed through regulatory filings and reflects activity involving the company’s stock on the Nasdaq.

Sector Focus: Biotechnology and Market Context

Immunome, Inc. is categorized within the biotechnology sector, which includes companies engaged in developing advanced medical and pharmaceutical solutions. Being part of the Nasdaq index aligns the company with a broad range of technology-driven and growth-oriented firms.

Institutional Activity and Market Presence

The activity by ProShare Advisors LLC highlights the ongoing engagement of institutional entities with firms like Immunome, Inc. Such participation often reflects interest in companies listed on major market indexes, including Nasdaq.

Index Listing and Market Role

Immunome, Inc.’s listing on the Nasdaq index situates it among key players in the biotech industry. This index is well-known for hosting firms that focus on innovation (NASDAQ:IMNM) and emerging technologies within the healthcare space.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.